autologous CD8+ melanoma-specific T cells

Autologous CD8 T lymphocytes against melanoma-associated antigens, with potential immunomodulating and antineoplastic activities. Following leukapheresis and the ex vivo expansion of cytotoxic T-lymphocytes, the autologous CD8+ melanoma-specific T cells are re-introduced into the melanoma patient. These cytotoxic T-cells recognize and kill the patient’s own melanoma cells. Check for active clinical trials using this agent. (NCI Thesaurus)

Related Posts